MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells
Plants are important sources of biologically active compounds and they provide unlimited opportunities for the discovery and development of new drug leads, including new chemotherapeutics. Miconidin acetate (MA) is a hydroquinone derivative isolated from E. hiemalis. In this study we demonstrated that MA was cytotoxic against acute leukemia (AL), solid tumor cells and cancer stem cells, with the strongest effect exhibited against AL. Furthermore, it was non-cytotoxic against non-tumor cells and did not cause significant hemolysis. MA blocks the G2/M phase and causes cytostatic effects, acting in a similar way to dexamethasone by increasing PML expression. The compound also triggered intrinsic and extrinsic apoptosis by modulating Bax, FasR and survivin expression. This led to an extensive mitochondrial damage that resulted in AIF, cytochrome c and endonuclease G release, caspase-3 and PARP cleavage and DNA fragmentation. We have further demonstrated that MA was strongly cytotoxic against neoplastic cells collected from patients with different AL subtypes. Interestingly, MA increased the cytotoxic effect of chemotherapeutics cytarabine and vincristine. This study indicates that MA may be a new agent for AL and highlights its potential as a new source of anticancer drugs.
KeywordsCell death Acute leukemia Cytotoxicity Apoptosis Miconidine acetate
This study was supported by grants and fellowship from CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) (Brazil). Santos-Silva M.C. is recipient of a Research Fellowship from CNPq (National Counsel of Technological and Scientific Development) (Brazil).
Mariana Maioral: Cell viability, FACS and WB experiments; manuscript writing.
Natália Stefanes: Synergic experiments with chemotherapeutics; manuscript writing.
Álisson Bigolin: Cell viability experiments; manuscript writing.
Gabriele Zatelli: Compound extraction, isolation and identification; manuscript writing.
Ana Philippus: Compound extraction, isolation and identification; manuscript writing.
Miriam de Barcellos Falkenberg: Manuscript review; experimental supervision.
Maria Cláudia Santos-Silva: Manuscript review; experimental supervision.
This study was supported by fellowships from CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) (Brazil) and CNPq (National Counsel of Technological and Scientific Development) (Brazil) n° 306682/2015–0.
Compliance with ethical standards
Conflict of interest
Author A (Mariana Franzoni Maioral) declares that she has no conflict of interest. Author B (Natália Marceli Stefanes) declares that she has no conflict of interest. Author C (Álisson Bigolin) declares that he has no conflict of interest. Author D (Gabriele Andressa Zatelli) declares that she has no conflict of interest. Author E (Ana Cláudia Philippus) declares that she has no conflict of interest. Author F (Miriam de Barcellos Falkenberg) declares that she has no conflict of interest. Author G (Maria Cláudia Santos-Silva) declares that she has no conflict of interest.
All procedures performed in this study involving human participants have been conducted with the ethical approval of relevant bodies and that such approvals are acknowledged within the manuscript (Medical Ethics Committee CEPSH n°746.486/2014).
Informed consent was obtained from all individual participants included in the study.
- 3.Zia Ul Haq M, Riaz M, Saad B (2016) Anthocyanins and human health: biomolecular and therapeutic aspects. Springer International Publishing, ChamGoogle Scholar
- 4.Singh S, Awasthi M, Pandey VP, Dwivedi U (2017) Natural products as Anticancerous therapeutic molecules with special reference to enzymatic targets topoisomerase, COX, LOX and aromatase. Curr Protein Pept SciGoogle Scholar
- 10.Sobral M, Proença C, Souza M, Mazine F, Lucas E (2015) Myrtaceae. In: Lista de Espécies da Flora do Brasil. Jardim Botânico do Rio de Janeiro. http://floradobrasil.jbrj.gov.br/. Accessed 03-21-2018
- 11.Ferreira FPS, Morais SR, Bara MTF, Conceição EC, Paula JR, Carvalho TC, Vaz BG, Costa HB, Romão W, Rezende MH (2014) Eugenia calycina Cambess extracts and their fractions: their antimicrobial activity and the identification of major polar compounds using electrospray ionization FT-ICR mass spectrometry. J Pharm Biomed Anal 99:89–96CrossRefGoogle Scholar
- 13.Junior C, De AR, Gomes GA, Ferreira RO, de Carvalho MG (2014) Chemical constituents and antioxidant activity of leaves and branches of Eugenia copacabanensis Kiaersk (Myrtaceae). Quím Nova 37:477–482Google Scholar
- 14.Falkenberg MB (1996) Chinone und andere Inhaltstoffe aus Eugenia hiemalis Cambessèdes und Paramyrciaria glazioviana (Kiaerskou) Sobral (Myrtaceae). 84p. Thesis (Doutorado em Pharmazeutische Chemie). Mathematisch-Naturwissenschaftlichen Fakultät, Universität BonnGoogle Scholar
- 20.Vasekar M, Rizvi S, Liu X, Vrana KE, Zheng H (2015) Novel immunotherapies for hematological malignancies. Curr Mol PharmacolGoogle Scholar
- 23.Peña-Morán OA, Villarreal ML, Álvarez-Berber L, Meneses-Acosta A, Rodríguez-López V (2016) Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines. Mol Basel Switz 21Google Scholar
- 24.Evans BC, Nelson CE, Yu SS, Beavers KR, Kim AJ, Li H, Nelson HM, Giorgio TD, Duvall CL (2013) Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J Vis Exp JoVEGoogle Scholar
- 26.Chizuka A, Suda M, Shibata T, Kusumi E, Hori A, Hamaki T, Kodama Y, Horigome K, Kishi Y, Kobayashi K, Matsumura T, Yuji K, Tanaka Y, Kami M (2006) Difference between hematological malignancy and solid tumor research articles published in four major medical journals. Leukemia 20:1655–1657CrossRefGoogle Scholar
- 33.Dahham SS, Tabana YM, Iqbal MA, Ahamed MBK, Ezzat MO, Majid ASA, Majid AMSA (2015) The anticancer, antioxidant and antimicrobial properties of the Sesquiterpene β-Caryophyllene from the essential oil of aquilaria crassna. Mol Basel Switz 20:11808–11829Google Scholar
- 40.Pedrini FS, Chiaradia LD, Licínio MA, de Moraes ACR, Curta JC, Costa A, Mascarello A, Creczinsky-Pasa TB, Nunes RJ, Yunes RA, Santos-Silva MC (2010) Induction of apoptosis and cell cycle arrest in L-1210 murine lymphoblastic leukaemia cells by (2E)-3-(2-naphthyl)-1-(3′-methoxy-4′-hydroxy-phenyl)-2-propen-1-one. J Pharm Pharmacol 62:1128–1136CrossRefGoogle Scholar
- 41.Salsman J, Stathakis A, Parker E, Chung D, Anthes LE, Koskowich KL, Lahsaee S, Gaston D, Kukurba KR, Smith KS, Chute IC, Léger D, Frost LD, Montgomery SB, Lewis SM, Eskiw C, Dellaire G (2017) PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4. Sci Rep 7:45038CrossRefGoogle Scholar
- 42.Mazza M, Pelicci PG (2013) Is PML a tumor suppressor? Front Oncol 3Google Scholar
- 47.Suzuki-Karasaki Y, Suzuki-Karasaki M, Uchida M, Ochiai T (2014) Depolarization controls TRAIL-sensitization and tumor-selective killing of Cancer cells: crosstalk with ROS. Front Oncol 4Google Scholar
- 48.Rojas F, Gonzalez D, Cortes N, Ampuero E, Hernández DE, Fritz E, Abarzua S, Martinez A, Elorza AA, Alvarez A et al (2015) Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling. Front Cell Neurosci 9Google Scholar